跳至主要內容

藥物交互作用

Defibrotide + Fondaparinux

嚴重程度: 禁忌併用

Defibrotide and Fondaparinux: contraindicated interaction.

最後更新

僅供醫療專業人員參考。本頁為簡要摘要,並非醫療建議,亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。

本頁的臨床內容僅提供英文版。

摘要

Defibrotide enhances fibrinolysis and has antithrombotic effects, so with fondaparinux the risk of serious bleeding is increased. Defibrotide labeling contraindicates concurrent systemic anticoagulant or fibrinolytic therapy.

用白話說明這項交互作用的意義

Defibrotide and Fondaparinux are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Defibrotide belongs to Cardiovascular; Fondaparinux belongs to Cardiovascular.

證據等級: Moderate

為什麼會發生

Additive pharmacodynamic effects on hemostasis through factor Xa inhibition plus enhanced fibrinolysis.

處置方式

Do not co-administer; hold fondaparinux during defibrotide treatment or use an alternative plan. Line maintenance or reopening of central lines is the usual exception.

可向藥師詢問的問題

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ 會員專屬

解鎖完整頁面

建立帳號並開始 Pro+ 試用,即可解鎖 Defibrotide 與 Fondaparinux 的完整臨床處置建議、補充說明、證據詳情及整張處方的交互作用檢查工具。

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

在網頁版免費試用 Pro+ 14 天,無需信用卡。

常見問題

Can I take Defibrotide with Fondaparinux?

MediHelp rates the interaction as contraindicated. Defibrotide and Fondaparinux are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Defibrotide enhances fibrinolysis and has antithrombotic effects, so with fondaparinux the risk of serious bleeding is increased. Defibrotide labeling contraindicates concurrent systemic anticoagulant or fibrinolytic therapy.

How serious is the interaction between Defibrotide and Fondaparinux?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not co-administer; hold fondaparinux during defibrotide treatment or use an alternative plan. Line maintenance or reopening of central lines is the usual exception.

What other medicines interact with Fondaparinux?

MediHelp also lists interactions of Fondaparinux with, for example, Ketorolac, Abciximab, Aceclofenac. The full list is on the Fondaparinux page.

在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查

在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用,並使用劑量工具。

依 A–Z 瀏覽 · 藥物交互作用

取得 App 登入